Friday Jul 3 | Market Wire
Novo Nordisk A/S -- Regulatory Approval
Novo Nordisk's Victoza receives marketing authorisation in Europe Novo Nordisk announced today that the European Commission has granted marketing authorisation for Victoza for the treatment of type 2 diabetes in adults.
Long-term effects of metformin on metabolism and microvascular and...
NEW booker hyperglycaemia NEW Abstract BACKGROUND: We investigated whether metformin hydrochloride has sustained beneficial metabolic and vascular effects in patients with type 2 diabetes mellitus .
Generex Sees Favorable Results From MetControl(tm) Chewing Gum...
Generex Biotechnology Corporation , the leader in drug delivery for metabolic diseases through the inner lining of the mouth, announced today that the company has reviewed the positive data from its bioequivalent study with MetControl , its proprietary metformin chewing gum product study conducted in November 2008.
CHMP Recommends 'Januvia(R)'(sitagliptin), From MSD, For Restricted First Line Use In European Union
Merck & Co., Inc. , which operates in many countries as Merck Sharp & Dohme , has received a positive opinion from the European Medicines Agency's Committee for Medicinal Products for Human Use recommending restricted first line use of 'Januvia' for the treatment of type 2 diabetes.
Updated May 17, 2006 Metformin A popular oral drug for treating Type 2 diabetes.
13:33]( ... )- ' ' s Y - Y - BW - Committee for Medicinal...
I'I I'IsIYI I I©I I- I I I IYI - BW - Committee for Medicinal Products for Human Use Recommends 'J... June 26, 2009 10:30 UTC Committee for Medicinal Products for Human Use Recommends 'Januvia?' , from MSD, for Restricted First Line Use in European Union European Commission Approves 'Januvia' and 'Janumet' for Combination Use with a PPARI3 ...
ONGLYZA (saxagliptin) Receives Positive Opinion in Europe for the Treatment of Type 2 Diabetes
AstraZeneca and Bristol-Myers Squibb Company have announced that their marketing authorisation application for ONGLYZA received a positive opinion from the Committee for Medicinal Products for Human Use for the treatment of type 2 diabetes in adults as add-on therapy with metformin, a thiazolidinedione or a sulphonylurea.
The Biomarkers Consortium Completes First Project to Show that...
Jun 25, 2009 - The use of adiponectin, a hormone derived from fat cells, was confirmed as a robust biomarker predictive of glycemic efficacy in Type 2 diabetes and healthy subjects, after treatment with peroxisome proliferator-activated receptor-agonists , but not after treatment with non-PPAR drugs such as metformin.
Wal-Mart, online pharmacies top affordable drug list: ADA
A study discussed at the American Diabetes Association meeting suggests that patients who do their research on finding the least expensive meds may save thousands of dollars per year.
This is the continuation of updates on rejuvenation/regenerative therapies, some of which were discussed at a recent medical conference held in Kuala Lumpur.
Benefit of glinides is not proven
The benefit of glinides in the treatment of type 2 diabetes is not scientifically proven.
"Pregnant, Type 2 and worried!!!! Please help"
Hello everyone - I am new to the boards. I am diabetic and found out a few weeks ago that I was pregnant.
Metformin, Diabetic Medication, Battling Cancer by Forming Memory T-Cells
When metformin was given to mice they produced more immune system memory cells. Metformin works in diabetics by energizing the AMP or activated protein kinase.
Study Shows Combination Therapy With Januvia™ And Pioglitazone ...
New investigational data presented at the American Diabetes Association 69th Annual Scientific Sessions showed that initial combination therapy with 'Januvia' and pioglitazone* substantially improved blood sugar control.
Diabetes drug may help cancer treatments work better
JULIE STEENHUYSEN Reuters, Thursday, Jun. 11, 2009 03:25AM EDT A common diabetes pill may help trick the body into making more powerful immune system cells that could help make vaccines and cancer treatments work better, according to a team of Canadian and U.S. researchers.
What is the relationship between hepatocellular carcinoma and type 2 diabetes mellitus?
Hepatocellular carcinoma is the fifth most common malignancy worldwide and the third leading cause of cancer-related deaths.
Rosiglitazone Does Not Harm Bone Healing When Combined With Metformin In Rats
Taking the diabetes medications metformin and rosiglitazone together reverses the adverse effects on bone of rosiglitazone treatment alone in an experimental model, according to a new study done in rats.
Initial Therapy With Janumeta Provided Significantly Greater Blood...
New data presented at the American Diabetes Association 69th Annual Scientific Sessions showed that initial treatment with 'Janumet'* provided significantly greater blood sugar improvements in drug-naive** patients with type 2 diabetes, compared with metformin alone.[i] "In this study, initial combination therapy with the fixed-dose combination ...
New Post-Hoc Analyses Show Januviaa (sitagliptin) Provided...
New post-hoc analyses, presented at the American Diabetes Association 69th Annual Scientific Sessions, of data pooled from studies of 104 weeks in duration showed 'Januvia' , when taken alone* or in combination with metformin , provided significant blood sugar lowering, which was sustained over two years.[i] "These analyses show that, among ...
GlaxoSmithKline reports new Phase II study data with diabetes treatment SYNCRIA
Albiglutide is an investigational biological, injectable form of human GLP-1 - a peptide that acts throughout the body to help maintain normal blood sugar levels and to control appetite.